1. Lee JH, Chang JY, Lee KH. Syringoma: a clinicopathologic and immunohistologic study and results of treatment. Yonsei Med J. 2007. 48:35–40.
Article
2. Wallace ML, Smoller BR. Progesterone receptor positivity supports hormonal control of syringomas. J Cutan Pathol. 1995. 22:442–445.
Article
3. Yorganci A, Kale A, Dunder I, Ensari A, Sertcelik A. Vulvar syringoma showing progesterone receptor positivity. BJOG. 2000. 107:292–294.
4. Timpanidis PC, Lakhani SR, Groves RW. Progesterone receptor-positive eruptive syringoma associated with diabetes. J Am Acad Dermatol. 2003. 48(5 Suppl):S103–S104.
Article
5. Trager JD, Silvers J, Reed JA, Scott RA. Neck and vulvar papules in an 8-year-old girl. Arch Dermatol. 1999. 135:203–208.
Article
6. Bal N, Aslan E, Kayaselcuk F, Tarim E, Tuncer I. Vulvar syringoma aggravated by pregnancy. Pathol Oncol Res. 2003. 9:196–197.
Article
7. Huang YH, Chuang YH, Kuo TT, Yang LC, Hong HS. Vulvar syringoma: a clinicopathologic and immunohistologic study of 18 patients and results of treatment. J Am Acad Dermatol. 2003. 48:735–739.
Article
8. Fernandez-Flores A, Gonzalez-Montero JM. Eruptive syringomas in an adult woman. Rev Esp Patol. 2001. 34:325–328.
Article
9. Rhodes A, Jasani B, Balaton AJ, Barnes DM, Anderson E, Bobrow LG, et al. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays. Am J Clin Pathol. 2001. 115:44–58.
Article
10. Neves JI, Begnami MD, Arias V, Santos GC. Antigen retrieval methods and estrogen receptor immunoexpression using 1D5 antibody: a comparative study. Int J Surg Pathol. 2005. 13:353–357.
Article
11. Shi SR, Imam SA, Young L, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem. 1995. 43:193–201.
Article